This book focuses on the design and synthesis of novel sustainable nanomaterials for the diagnosis and treatment of infectious diseases, offering potential benefits in terms of efficacy, biocompatibility, and environmental impact.
The fifteen chapters of this book provide a comprehensive overview of how sustainable nanotechnology is revolutionizing infectious disease management and bridging the gap between the fundamental principles of nanotechnology and their practical applications in the fight against infectious diseases. Topics covered include: the emergence of multidrug-resistant pathogens and the limitations of existing therapies; challenges in infectious disease management, including the emergence of multidrug-resistant pathogens and the limitations of existing therapies; nanopharmacology and drug therapy in the treatment of infectious diseases; advances in nanomaterial-based drug delivery systems, vaccines, and diagnostics, and the future of personalized medicine; nanotheranostics mechanisms that describe how nanomaterials can be engineered to simultaneously diagnose and treat infections; nanopharmaceutical systems that help enhance the efficacy and precision of therapeutics; Biocompatibility and toxicity of nanomaterials in the diagnosis and treatment of infectious diseases; Regulatory perspectives of nanomaterials to ensure that their safety and efficacy standards are met; Green synthesis of reduced graphene oxide, carbon dots and its composites for infectious diseases and biosurfactants; Polymer-designed nanomaterials highlighting their potential to create more effective and sustainable therapeutic options; How to engineer nanomaterials for simultaneous diagnosis and treatment of infections.
